Beck Bode LLC’s Zoetis ZTS Stock Holding History

Beck Bode LLC’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,766	Closed	-$262K	–	262
2022 Q3	$262K	Sell	1,766 -107	-6%	-$17.9K	0.06%	158
2022 Q2	$322K	Buy	1,873 +634	+51%	+$110K	0.07%	147
2022 Q1	$234K	Buy	+1,239	New	+$245K	0.05%	138

Other funds holding ZTS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Beck Bode LLC's ZTS Position: Q4 2022 in Review

Beck Bode LLC sold out of Zoetis (ZTS) in Q4 2022, closing a stake of 1,766 shares — an estimated $262K sold.

Beck Bode LLC first reported a position in ZTS in Q1 2022 and held it in 3 quarters. The position peaked at $322K in Q2 2022. 1,519 funds tracked by Wall St. Rank hold ZTS as of Q4 2022.

Beck Bode LLC reported no remaining Zoetis position as of Q4 2022 after selling out during the quarter.
Beck Bode LLC sold 1,766 Zoetis shares in Q4 2022, an estimated $262K.
Beck Bode LLC first reported a position in Zoetis in Q1 2022 and held it in 3 quarters.
Beck Bode LLC's Zoetis position peaked at $322K in Q2 2022.
1,519 funds tracked by Wall St. Rank held Zoetis as of Q4 2022.

Based on Beck Bode LLC's 13F filing for Q4 2022, filed 8 Feb 2023.